RECRUITINGOBSERVATIONAL
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
About This Trial
This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).
Who May Be Eligible (Plain English)
Who May Qualify:
1. Age ≥ 18 years;
2. Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
3. Patients fully informed about the trial procedures who provide written willing to sign a consent form.
Who Should NOT Join This Trial:
1. Patients presenting with any of the following:
- Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months;
- Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
- Variant angina (Prinzmetal's angina);
- Coronary artery dissection;
- Thrombophilia;
- Stent underexpansion.
2. Presence of psychiatric disorders;
3. Known inability to complete expected study follow-up for any reason;
4. Patients deemed ineligible for enrollment by the investigator.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Age ≥ 18 years;
2. Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
3. Patients fully informed about the trial procedures who provide written informed consent.
Exclusion Criteria:
1. Patients presenting with any of the following:
* Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months;
* Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
* Variant angina (Prinzmetal's angina);
* Coronary artery dissection;
* Thrombophilia;
* Stent underexpansion.
2. Presence of psychiatric disorders;
3. Known inability to complete expected study follow-up for any reason;
4. Patients deemed ineligible for enrollment by the investigator.
Treatments Being Tested
OTHER
Treatment made by experienced clinicians
Treatment made by experienced clinicians
Locations (1)
Jia Lei
Beijing, Beijing Municipality, China